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Gli transcription factors are downstream targets of the Hedgehog signaling pathway. Two of the
three Gli proteins harbor gene transcription repressor function in the N-terminal half. We have ana-
lyzed the sequences and identiﬁed a potential repressor domain in Gli2 and Gli3 and have tested this
experimentally. Overexpression studies conﬁrm that the N-terminal parts harbor gene repression
activity and we mapped the minimal repressor to residues 106 till 236 in Gli3. Unlike other mecha-
nisms that inhibit Gli induced gene transcription, the repressor domain identiﬁed here does not
utilize Histone deacetylases (HDACs) to achieve repression, as conﬁrmed by HDAC inhibition studies
and pull-down assays. This distinguishes the identiﬁed domain from other regulatory parts with
negative inﬂuence on transcription.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The morphogens of the Hedgehog (Hh) family are crucial for
numerous developmental processes during embryogenesis as well
as postnatally. In fact the Hh pathway is one of the four major sig-
naling systems that are controlling the major developmental pro-
cesses. Gli proteins are Zn-ﬁnger transcription factors and are
targets as well as mediators of the Hh signaling pathway [1]. Mam-
mals have three Gli genes encoding Gli1, Gli2 and Gli3 that are
orthologs of the Drosophila transcription factor Cubitus interruptus
(Ci). Ci is mainly a transcriptional activator in its full-length form
that dominates in the presence of Hh. In the absence of Hh, a por-
tion of Ci is proteolytically cleaved to produce an N-terminal gene
repressor form. In a similar fashion Gli2 and Gli3 can undergo pro-
teolysis to produce a gene repressor form. The full-length forms of
Gli2 and Gli3 act as gene activators. A repressor form of Gli1 cannot
be generated and Gli1 is considered to be a strong gene activator.
The dominating role of Gli2 appears to be gene activation whereas
Gli3 often has a gene repression role, mediated by the N-terminal
part. In humans, several GLI3 morphopathies have been described,
which can be broadly divided into two classes: Greig’s syndromeal Societies. Published by Elsevier
terruptus; DMEM, Dulbecco’s
C, histone deacetylases; Hh,
tatin-A.
d).caused by total loss of GLI3 function and Pallister–Hall syndrome
(PHS)/other postaxial polydactylies that are presumed to be caused
by abnormally high repressor generation. The ﬁrst identiﬁed muta-
tions causing PHS were found in the GLI3 gene [2]. Since then sev-
eral Gli3 mutations have been identiﬁed in the same region (exons
12–14). Both original mutations are single nucleotide deletions
that lead to frame shift and premature translational stop [2]. The
produced peptide has 691 residues (compared to the 1596 residue
full-length protein) but contain alternative residues in the last
approximately 20 residues, encoded after the mutations [2]. It
was shown that the corresponding peptide Gli3-PHS (residues 1–
674) indeed has strong gene repressor activity, which may explain
the phenotypes of these patients [3]. Due to its vast impact on cell
differentiation and proliferation aberrant Hh signaling is involved
in many cancers and several gene members of the pathway are
either proto-oncogenes or tumor suppressors [4]. A thorough anal-
ysis of the Gli proteins is therefore important in order to under-
stand the associated developmental biology and pathology as
well as related carcinogenesis.
To further analyze the repressor function in the PHS part of Gli3
and to identify the speciﬁc repressor sequence, we made a series of
GLI3 constructs and evaluated their activity in cellular gene
regulation assays. This led to the identiﬁcation of a speciﬁc repres-
sor domain in GLI3 also conserved in GLI2 but not in GLI1. The
repressor function of this domain is not dependent on histone
deacetylases (HDAC) and therefore works through a different
mechanism.B.V. Open access under CC BY-NC-ND license.
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2.1. DNA constructs
Gli1, Gli1(1–407), Gli3, Gli3-PHS, Gli3DRD and Gli3-PHSDRD all
of human origin were cloned into pcDNA3.1His expression vector
(some of these were described before [3,5]). The 12GliRE-luc and
b-galactosidase (b-gal) constructs were described before [5]. The
Gli3 repressor domain (residues 106–246) and shorter versions
were subcloned into the pFA vector in frame with the DNA Binding
Domain (DBD) of yeast Gal4 (Stratagene, La Jolla, CA, USA). As Gal4
reporter construct was used the pMN-Luc plasmid containing a
thymidine kinase promoter with ﬁve tandem repeats of the yeast
GAL4 binding sites that control expression of the ﬁreﬂy luciferase
gene. For recruitment of HDAC in gene silencing we employed
the C-terminal HDAC dependent repressor domain of the rat REST
protein [6] cloned in frame with GAL4 DBD in pFA.
2.2. Cell culture
HEK293 cells were grown and transfected as previously de-
scribed [7]. The cells were maintained in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM) supplemented with 10% fetal calf serum
(FCS) (PAA Laboratories, Pasching, Austria), streptomycin and pen-
icillin (100 units/ml; Invitrogen, Carlsbad, CA, USA). Cells were
grown at 37 C and 5.0% CO2 in cell culture incubator. One day be-
fore transfection cells were plated into the required growth plates.
Shh-Light2 cells were grown in the same medium as HEK293
supplemented with G 418 (400 lg/ml; Sigma–Aldrich, St. Louis,
MO, USA) and Zeocine (100 mg/ml; Invitrogen). At 24 h post trans-
fection the medium was changed to low-serum medium (0.5% of
FCS; PAA Laboratories).
2.3. Luciferase assays
Transfections for luciferase assays were performed in 24-well
plates. Assessment of Gli1, Gli3 and Gli3-PHS in HEK293 cells
was done as previously described [5,7]. Assessment in Shh-L2 cells
was performed as described [8], using the incorporated luciferase
gene as measurement of gene activation and the co-transfected
b-gal as control. Transfections were done with the same amount
of total DNA by using empty vector to compensate.
For measurement of the Gli3-RD deletion constructs we trans-
fected HEK293 cells also using the b-gal construct as control. The
amount of reporter plasmid (pMN-Luc) used was 300 ng per well
and the effector plasmids (pFA Gal4 fusions with RD segments)
were 30 ng per well. For normalization we used 100 ng of pCMV-
b-gal. As a transfecting agent we used polyethyleneimine (PEI;
Sigma–Aldrich) 1 lg per well. DNA and PEI were mixed in 50 ll
of DMEM. An additional 150 ll of DMEM was added to the DNA/
PEI mixture and then applied to the cells. After 2 h the medium
was exchanged for DMEM with 10% FCS. On the following day
the medium was changed again and where required, trichostatin-
A (TSA) was added at 0.2, 0.5, and 1 lM. Cells were harvested after
an additional 24 h. Fireﬂy luciferase and b-gal assays were
performed in Ascent FL ﬂuoroskan with the Luciferase Assay Kit
(BioTherma, Darlarö, Sweden) and Galacto-Light Plus System
(Applied Biosystems, Foster City, CA, USA). In assays measuring
HDAC induced gene silencing we used the REST expressing pFA
vector as positive control of HDAC recruitment.
2.4. Immunoprecipitation and HDAC enzymatic assay
To test the association of Gli3-RD with HDAC we immunopre-
cipitated Gli3-RD and measured HDAC enzymatic activity of theprecipitate. As a positive control we immunoprecipitated Sin3A
that is known to be in a complex with HDAC1 and HDAC2.
We transfected HEK293 cells with Gli3-RD in 15 cm culture
dishes. The DNA/PEI complex was prepared as follows: 30 lg of
Gli3-RD DNA was mixed with 60 lg of PEI per plate in 500 ll of
DMEM. After 10 min of incubation 9 ml of DMEM was added to
the DNA/PEI mixture and then applied to the culture dish. After
2 h the medium was exchanged for DMEM with 10% FCS. On the
following day, the mediumwas changed again and cells were lysed
in PBS with 1% Triton X-100 (Sigma–Aldrich) after an additional
24 h.
For immunoprecipitation of Gli3-RD 5 ll of anti-Gal4 polyclonal
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were
incubated with 30 ll Protein G agarose (Amersham Biosciences,
Bucks, UK). After 1 h 1 ml of cell lysate was added and immunopre-
cipitation was performed at 4 C overnight. The immunoprecipita-
tion of Gli3-RD was analyzed by Western blot using Gal4
monoclonal antibody (Santa Cruz Biotechnology). Sin3A was
immunoprecipitated and detected as described above using an anti
mSin3A antibody (Santa Cruz Biotechnology).
HDAC activity was measured using a ﬂuorescent substrate Fluor
de Lys (Biomol, Plymouth Meeting, PA, USA) that contains an acet-
ylated lysine side chain. This substrate was incubated with immu-
noprecipitated Gli3-RD or mSin3A. If the immunoprecipitate
contain HDAC’s the substrate is deacetylated and a ﬂuorophore is
produced. Assays were performed according to manufacturer’s
instructions, and measured in Tecan GENios pro microplate spec-
troﬂuorometer (Tecan Group, Männedorf, Switzerland) with the
Magellan V5.03 system (Tecan Group).
3. Results and discussion
The Gli3-PHS part (residues 1–673) was shown to contain gene
repressor activity [3]. Using a two-hybrid screening technology it
was shown that almost the same part (residues 1–613) in Gli3
binds to Ski [9]. The Ski binding site on Gli3 was determined to
the region from residue 152 to 397 using pull-down assays [9].
Since Ski is known to be part of a gene repressor complex including
HDAC, it was suggested that Gli3 exerts its repressor activity
through binding of Ski and recruitment of HDAC [9]. However,
most of the Ski binding region is conserved between all three Gli
proteins, suggesting that Ski binding and HDAC recruitment is part
of a general transcription termination signal common to all Gli
proteins. Likewise, the SUFU binding site (BS) on Gli proteins
(SYGH) is also found in all three Gli proteins [10]. Also SUFU is
known to recruit HDAC through recruitment of SAP18 and Sin3A
[11] and therefore, SUFU binding may also be regarded as a general
mechanism to turn off Gli mediated transcription. Recently, two
sites in Gli1 were identiﬁed as responsible for protein degradation
[12]. One peptide (degron) was in the C-terminal part (DC) whereas
the other was found in the N-terminal part (DN). In fact the DN
peptide is located very close to the SUFU binding site and is con-
served also in Gli2 and Gli3. A previous study identiﬁed the peptide
94–280 of Gli2 as a repressor part and removal of a corresponding
part in Gli3 (residues 1–344) had strong positive effect on
transcription [13]. In contrast, when this part of Gli1 (residues
1–134) was removed there was no effect on transcription as
compared to wild type protein [13]. The last approximately 100
residues of this region is conserved between the three Gli proteins,
and those are the parts that overlap with the identiﬁed Ski binding
part, contain DN and the SYGH peptide. Fig. 1A shows a schematic
alignment of the N-terminal parts of mammalian Gli proteins, until
the end of the Zn-ﬁngers (corresponding to the PHS-domain), with
indications of the respective domains describe above. From this
work and a previous paper [3] it is suggested that the gene
Fig. 1. Sequence analyzes of the N-terminal halves of Gli1, Gli2 and Gli3, as well as analyzes of the transcriptional regulation by Gli1 and Gli3 and the PHS domain of Gli3. (A)
Schematic alignment of Gli1, Gli2 and Gli3 in the N-terminal half until the end of the Zn-ﬁnger DBD (Zn-ﬁnger; lined). The suggested repressor domain (Rep Dom; grey) is
only found in Gli2 and Gli3. The sequences for the Sufu binding site (Sufu BS) and DegronN (Degron N) is found in all three Gli proteins (hatched and black, respectively).
Above is a line indicating the presumed Ski binding region (Ski BS). Both Ski and Sufu are likely to recruit HDACs through Sin3A and induce transcriptional termination by this
mechanism. (B) HEK293 cells were transfected with a Gli responsive luciferase reporter and Gli1, Gli3 or N-terminal parts of these corresponding to the PHS domain, or
combinations to assess the effects of these on transcription. Error bars indicate the standard deviations of triplicate analyzes.
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and Gli3. The physiological signiﬁcance was shown by regulation
of PTCH1 transcription [3]. We suggest that the other mechanisms
with negative gene transcription activity (Ski BS, SUFU BS and DN
peptide) that are common to all Gli proteins, are general means
to terminate Gli induced transcription. At least two of these path-
ways (Ski and SUFU through interaction with SAP18 and Sin3A)
probably recruit HDACs to terminate transcription and increase
the degradation of the Gli protein.
As stated above it has previously been shown that the Gli3-PHS
domain is a repressor of both basal and Gli3 induced transcription
[3]. However, since Gli3 only induces a modest transcriptional acti-
vation we wanted to test the PHS domain together with the much
stronger transcriptional activator Gli1. Therefore, in HEK293 cells
Gli1, Gli3 and Gli3-PHS were transfected alone or in combinations
together with a Gli-luciferase reporter construct [5]. As shown be-
fore [5,7] Gli1 is an effective activator of transcription whereas Gli3only activates weakly (Fig. 1B). The transcriptional activation of
Gli1 is strongly inhibited by co-expressing Gli3-PHS. Expression
of full-length Gli3 also leads to repression of Gli1 induced tran-
scription, although signiﬁcant activity is seen. Gli3 on its own gives
much lower activity but it appears that repression of Gli1 is a more
pronounced effect (3–4 times Gli3 induction vs. 6 times repres-
sion). In other words, not only does the Gli3-PHS have repressor
activity on its own [3] it also strongly repress Gli1 induced
transcription. Expression of the Gli1 peptide corresponding to
Gli3-PHS (residues 1–407) only weakly suppresses Gli1 induced
transcription, which is likely to be due to competitive expression
and suggest that the N-terminal of Gli1 does not exert any signiﬁ-
cant repressor function.
In order to analyze the constructs in a more in vivo-like setting,
we turned to the Shh-Light2 (Shh-L2) cells that have a Gli-induc-
ible luciferase reporter construct incorporated into the genome.
[14]. Transfection of these cells is less efﬁcient and the transcrip-
Fig. 2. Analyzes of the repressor function of the Gli3-PHS domain and the repressor
domain (RD) in Shh-L2 cells. Shh-L2 cells (with an incorporated Gli responsive
luciferase reporter gene) were transfected with Gli1, Gli3, Gli3-PHS, Gli3DRD, Gli3-
PHSDRD or combinations of these to assess the effect on transcription alone or on
the Gli1 induced transcription. The analyzes were performed at least three times
and error bars indicate the standard deviations.
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(Fig. 2). The induction posed by Gli3 is also lower but the difference
is not as pronounced as in HEK293 cells. This may indicate that in
the Shh-L2 cells the transcriptional regulation of the reporter is
different from the vector-based one used in HEK293 cells.
Alternatively, the differences could reﬂect differences in the ratios
of the expressed Gli peptides. In the Shh-L2 cells Gli3 does not af-
fect Gli1 induced transcription as much as in the HEK293 cells.Fig. 3. Determination of the minimal repressor domain of Gli3. The repressor domain (re
assessed for repression of Gal4 induced transcription in HEK293 cells (mock). Also a l
signiﬁcant repressor function (residues 1–480). The analyzes were performed three to ﬁHowever, the pattern for both Gli3 and Gli3-PHS induced Gli1
repression is the same as in HEK293 cells, showing that the PHS
domain is a strong repressor.
Based on the alignment we made deletion constructs of Gli3
and Gli3-PHS that lack residues 105–246 (Gli3DRD and Gli3-
PHSDRD), corresponding to the grey area in Gli2 and Gli3
(Fig. 1A). Removal of this part enhances the gene transcription
induction of Gli3 (Fig. 2). This is conﬁrmed in the Gli1/Gli3DRD
combination, though the effect is small. The effect is much more
pronounced when comparing the repression of Gli3-PHS on Gli1
induced transcription to that of Gli3-PHSDRD (Fig. 2). In the latter
case the repression is reduced almost 10 times. This clearly indi-
cates that the particular sequence harbors signiﬁcant gene tran-
scription repression activity. In fact most (if not all) the repressor
function is located in this part of the PHS domain.
We then proceeded to make constructs containing this repres-
sor domain (RD) and parts of this in frame with Gal4 DBD and used
the constructs to assess the minimal RD of Gli3. We used HEK293
cells that were also transfected with a Gal4 DBD responsive lucif-
erase reporter. The DBD of the Gli3-RD fusion peptides bind to
the reporter plasmid at the GAL4 binding sites. Compared to Gal4
alone (pFA vector) the N-terminus of Gli3 and the Gli3-RD signiﬁ-
cantly represses gene expression (Fig. 3). However, shorter ver-
sions of the Gli3-RD lose the ability to repress transcription and
therefore we mapped the minimal RD of GLI3 between residues
106 and 235. When the RD is shortened beyond these residues
the repression is reduced or lost.
The suggested Ski binding site on Gli3 has not been exactly
mapped (it is in the region from residue 152 to 397 [9]) and may
overlap with the identiﬁed repressor part. Since Ski and SUFU re-
cruits HDACs to exert their inhibitory role, we wanted to test if
the repressor function described here depends on the same mech-
anism or not. We transfected HEK293 cells with either Gli3-RD or
the repressor domain of REST (that serve as positive control since it
depend on HDAC to repress transcription) and tested the effect of
the HDAC inhibitor TSA as shown in Fig. 4. Again the Gli3-RD sup-
presses transcription but there is not any effect of TSA up to 1 lM.sidues 105–246) or parts of this were expressed together with the DBD of Gal4 and
arger part of the Gli3 N-terminal part was measured since this is known to have
ve times and error bars show the standard deviations.
Fig. 4. HDAC recruitment study of the Gli3 repressor domain. HEK293 cells were
transfected with Gli3-RD (squares) or the repressor domain of REST (positive
control, triangles) and treated with increasing amounts of the HDAC inhibitor TSA.
As negative control we used cells transfected with empty vector (diamonds). The
analyzes were performed three to six times and the error bars indicate standard
deviations.
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This shows that Gli3-RD induced repression is not dependent on
HDACs in the way REST is.
As a further control we used pull-down assays to assess if there
is any binding of Gli3-RD to HDACs. In cells overexpressing Gli3-RD
fused to Gal4 DBD we used anti-Gal4 antibodies to precipitate the
fusion protein. HDAC activity was then assessed in the precipitates.
Neither Gal4 DBD nor the fusion protein showed any signiﬁcant
HDAC binding (not shown). As a positive control we also immuno-
precipitated Sin3A from the HEK293 cells using an mSin3A anti-
body. In this precipitate there was signiﬁcant HDAC activity.
Sin3A is a transcriptional regulator known to recruit HDACs to
induce gene silencing [15,16]. Both Ski and SUFU recruits HDACs
through Sin3A. Thus, the repression induced by the Gli3-RD is
through a different mechanism than that of Ski and SUFU.
When considering that HDACs are involved in more perma-
nently shutting down a target gene, this also makes good sense.
This mechanism is probably more useful when drastic measures
are required, e.g. when Hh signaling ceases, or when other signals
determines that Gli induced transcription has to end. Therefore,
these signals (Ski/SUFU/HDAC) [9,11] are probably common to all
the Gli proteins. Also the degradation signal (DN) is of this general
category and leads to removal of the targeted Gli protein and we
suggest that the Ski and SUFU signals recruit HDACs to terminate
Gli induced transcription at the Gli binding site on DNA (Fig. 1).
In contrast our results clearly suggest that the gene transcription
repression exerted by the N-termini of Gli2 and Gli3 is mediated
by the repressor domain identiﬁed here and indicated with grey
in Fig. 1A. We also suggest that the Ski binding site is strictly
localized in the region common to all three Gli proteins, but a more
exact mapping of the Ski binding site requires further experimen-
tation. It remains to be investigated by which mechanism Gli3-RD
regulates transcription. Perhaps the domain recruits other proteinsthan HDACs or interacts (physically or functionally) with the tran-
scriptional machinery. It has been shown that Gli3 interacts with
and regulate gene transcription via mediator [17] and perhaps
the repressor domain it able to inﬂuence this interaction. However,
the mediator binding site is localized at the C-terminal part of Gli3
[17] and the Gli3-PHS like repressor that is generated in vivo is not
likely to bind mediator, but may exert its repressor function by an
independent mechanism. It is clear that the repression is not
dependent on HDACs and investigations of the mechanism of
repression have been initiated.
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